Chen M L, Chiou W L
J Pharmacokinet Biopharm. 1983 Oct;11(5):515-27. doi: 10.1007/BF01062209.
The concentration-dependent clearance of methotrexate (MTX) and its metabolite, 7-hydroxy-methotrexate (7-OH-MTX), was demonstrated in 5 rabbits using 7 infusion rates (10.5-323 mg/hr). Mean total body clearance (from 34.3 to 13.1 ml/min) and mean renal clearance (from 25.6 to 7.6 ml/min) of MTX were found to decrease with increasing steady-state plasma concentrations (from 5.1 to 412 micrograms/ml), whereas nonrenal clearances remained relatively constant. An essentially steady-state plasma level of 7-OH-MTX was achieved during each MTX infusion, and its renal clearance also decreased (from 37.3 to 6.5 ml/min) with increasing metabolite levels (from 1.8 to 293 micrograms/ml). Saturable renal tubular secretion appeared operative for both drug and metabolite since their renal clearance (based on the free drug) to inulin clearance ratios were much greater than unity and the ratios were markedly reduced in 2 rabbits after probenecid treatment. Plasma protein binding of MTX (56%) and 7-OH-MTX (49%) were independent of concentrations between 0.1 and 300 micrograms/ml. Negligible MTX metabolism was found in rabbit kidney homogenates, thus validating renal clearance measurement in the present study.
在5只兔子中,使用7种输注速率(10.5 - 323毫克/小时)证明了甲氨蝶呤(MTX)及其代谢产物7 - 羟基甲氨蝶呤(7 - OH - MTX)的浓度依赖性清除率。发现MTX的平均全身清除率(从34.3降至13.1毫升/分钟)和平均肾清除率(从25.6降至7.6毫升/分钟)随着稳态血浆浓度的增加(从5.1至412微克/毫升)而降低,而非肾清除率保持相对恒定。在每次MTX输注期间,7 - OH - MTX达到基本稳态血浆水平,并且其肾清除率也随着代谢产物水平的增加(从1.8至293微克/毫升)而降低(从37.3降至6.5毫升/分钟)。由于药物和代谢产物的肾清除率(基于游离药物)与菊粉清除率之比远大于1,并且在丙磺舒治疗后2只兔子中的比值明显降低,因此可饱和的肾小管分泌似乎对药物和代谢产物均起作用。MTX(56%)和7 - OH - MTX(49%)的血浆蛋白结合率在0.1至300微克/毫升之间与浓度无关。在兔肾匀浆中发现MTX代谢可忽略不计,从而验证了本研究中的肾清除率测量。